Effect of Targeted Agents on the Endocrine Response of Breast Cancer in the Neoadjuvant Setting: A Systematic Review

by Grassadonia, Antonino, Caporale, Marta, Tinari, Nicola, Zilli, Marinella, DeTursi, Michele, Gamucci, Teresa, Vici, Patrizia, Natoli, Clara
Published in J Cancer (2015)

Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review

by Sperduti, Isabella, Vici, Patrizia, Tinari, Nicola, Gamucci, Teresa, De Tursi, Michele, Cortese, Giada, Grassadonia, Antonino, Iacobelli, Stefano, Natoli, Clara
Published 2013

Breast Cancer “Tailored Follow-up” in Italian Oncology Units: A Web-Based Survey

by Natoli, Clara, Brocco, Davide, Sperduti, Isabella, Nuzzo, Antonio, Tinari, Nicola, De Tursi, Michele, Grassadonia, Antonino, Mazzilli, Lorenzo, Iacobelli, Stefano, Gamucci, Teresa, Vici, Patrizia
Published 2014

Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trial...

by Grassadonia, Antonino, Sperduti, Isabella, Vici, Patrizia, Iezzi, Laura, Brocco, Davide, Gamucci, Teresa, Pizzuti, Laura, Maugeri-Saccà, Marcello, Marchetti, Paolo, Cognetti, Gaetana, De Tursi, Michele, Natoli, Clara, Barba, Maddalena, Tinari, Nicola
Published in J Clin Med (2018)

Anthropometric, clinical and molecular determinants of treatment outcomes in postmenopausal, hormone receptor positive metastatic breast cancer patients treated with fulvestrant: R...

by Pizzuti, Laura, Natoli, Clara, Gamucci, Teresa, Mauri, Mariella, Sergi, Domenico, Di Lauro, Luigi, Paoletti, Giancarlo, Ruggeri, Enzo, Iezzi, Laura, Sperduti, Isabella, Mentuccia, Lucia, Fabbri, Agnese, Maugeri-Saccà, Marcello, Moscetti, Luca, Barba, Maddalena, Vici, Patrizia
Published in Oncotarget (2017)

Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a re...

by Grassadonia, Antonino, Di Marino, Pietro, Ficorella, Corrado, Cortellini, Alessio, Cannita, Katia, Parisi, Alessandro, Gamucci, Teresa, Zoratto, Federica, Vici, Patrizia, Barba, Maddalena, Porreca, Ettore, Neri, Matteo, Veronese, Angelo, Natoli, Clara, De Tursi, Michele, Tinari, Nicola
Published in J Cancer (2019)

Neoadjuvant Endocrine Therapy in Breast Cancer: Current Knowledge and Future Perspectives

by Barchiesi, Giacomo, Mazzotta, Marco, Krasniqi, Eriseld, Pizzuti, Laura, Marinelli, Daniele, Capomolla, Elisabetta, Sergi, Domenico, Amodio, Antonella, Natoli, Clara, Gamucci, Teresa, Vizza, Enrico, Marchetti, Paolo, Botti, Claudio, Sanguineti, Giuseppe, Ciliberto, Gennaro, Barba, Maddalena, Vici, Patrizia
Published in Int J Mol Sci (2020)

Neoadjuvant Immune-Checkpoint Blockade in Triple-Negative Breast Cancer: Current Evidence and Literature-Based Meta-Analysis of Randomized Trials

by Marinelli, Daniele, Mazzotta, Marco, Pizzuti, Laura, Krasniqi, Eriseld, Gamucci, Teresa, Natoli, Clara, Grassadonia, Antonino, Tinari, Nicola, Tomao, Silverio, Sperduti, Isabella, Sanguineti, Giuseppe, Botticelli, Andrea, Fabbri, Agnese, Botti, Claudio, Ciliberto, Gennaro, Barba, Maddalena, Vici, Patrizia
Published in Cancers (Basel) (2020)

Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy

by Vici, Patrizia, Ercolani, Cristiana, Di Benedetto, Anna, Pizzuti, Laura, Di Lauro, Luigi, Sperati, Francesca, Terrenato, Irene, Gamucci, Teresa, Natoli, Clara, Di Filippo, Franco, Botti, Claudio, Barba, Maddalena, Mottolese, Marcella, De Maria, Ruggero, Maugeri-Saccà, Marcello
Published in J Exp Clin Cancer Res (2016)

Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial

by Moscetti, Luca, Fabbri, Maria Agnese, Natoli, Clara, Vici, Patrizia, Gamucci, Teresa, Sperduti, Isabella, Iezzi, Laura, Iattoni, Elena, Pizzuti, Laura, Roma, Carmine, Vaccaro, Angela, D’Auria, Giuliana, Mauri, Mariella, Mentuccia, Lucia, Grassadonia, Antonino, Barba, Maddalena, Ruggeri, Enzo Maria
Published in Oncotarget (2017)

Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios

by Pizzuti, Laura, Krasniqi, Eriseld, Barchiesi, Giacomo, Mazzotta, Marco, Barba, Maddalena, Amodio, Antonella, Massimiani, Gioia, Pelle, Fabio, Kayal, Ramy, Vizza, Enrico, Grassadonia, Antonino, Tomao, Silverio, Venuti, Aldo, Gamucci, Teresa, Marchetti, Paolo, Natoli, Clara, Sanguineti, Giuseppe, Ciliberto, Gennaro, Vici, Patrizia
Published in J Cancer (2019)

Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer

by Natoli, Clara, Vici, Patrizia, Sperduti, Isabella, Grassadonia, Antonino, Bisagni, Giancarlo, Tinari, Nicola, Michelotti, Andrea, Zampa, Germano, Gori, Stefania, Moscetti, Luca, De Tursi, Michele, Panebianco, Michele, Mauri, Maria, Ferrarini, Ilaria, Pizzuti, Laura, Ficorella, Corrado, Samaritani, Riccardo, Mentuccia, Lucia, Iacobelli, Stefano, Gamucci, Teresa
Published 2013

The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy

by Vici, Patrizia, Mottolese, Marcella, Pizzuti, Laura, Barba, Maddalena, Sperati, Francesca, Terrenato, Irene, Benedetto, Anna Di, Natoli, Clara, Gamucci, Teresa, Angelucci, Domenico, Ramieri, Maria Teresa, Lauro, Luigi Di, Sergi, Domenico, Bartucci, Monica, Dattilo, Rosanna, Pagliuca, Alfredo, Maria, Ruggero De, Maugeri-Saccà, Marcello
Published in Oncotarget (2014)

Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer

by Barba, Maddalena, Vici, Patrizia, Pizzuti, Laura, Di Lauro, Luigi, Sergi, Domenico, Di Benedetto, Anna, Ercolani, Cristiana, Sperati, Francesca, Terrenato, Irene, Botti, Claudio, Mentuccia, Lucia, Iezzi, Laura, Gamucci, Teresa, Natoli, Clara, Vitale, Ilio, Mottolese, Marcella, De Maria, Ruggero, Maugeri-Saccà, Marcello
Published in BMC Cancer (2017)

Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis

by Grande, Roberta, Natoli, Clara, Ciancola, Fabrizio, Gemma, Donatello, Pellegrino, Arianna, Pavese, Ida, Garufi, Carlo, Di Lauro, Luigi, Corsi, Domenico, Signorelli, Diego, Sperduti, Isabella, Cortese, Giada, Risi, Emanuela, Morano, Federica, Sergi, Domenico, Signorelli, Carlo, Ruggeri, Enzo Maria, Zampa, Germano, Russano, Marco, Gamucci, Teresa
Published in PLoS One (2016)

Analysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment

by Buglioni, Simonetta, Vici, Patrizia, Sergi, Domenico, Pizzuti, Laura, Di Lauro, Luigi, Antoniani, Barbara, Sperati, Francesca, Terrenato, Irene, Carosi, Mariantonia, Gamucci, Teresa, Vincenzoni, Cristina, Mariani, Luciano, Vizza, Enrico, Venuti, Aldo, Sanguineti, Giuseppe, Gadducci, Angiolo, Barba, Maddalena, Natoli, Clara, Vitale, Ilio, Mottolese, Marcella, De Maria, Ruggero, Maugeri-Saccà, Marcello
Published in Oncoimmunology (2016)

Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis

by Vici, Patrizia, Benedetto, Anna Di, Ercolani, Cristiana, Pizzuti, Laura, Lauro, Luigi Di, Sergi, Domenico, Sperati, Francesca, Terrenato, Irene, Dattilo, Rosanna, Botti, Claudio, Fabi, Alessandra, Ramieri, Maria Teresa, Mentuccia, Lucia, Marinelli, Camilla, Iezzi, Laura, Gamucci, Teresa, Natoli, Clara, Vitale, Ilio, Barba, Maddalena, Mottolese, Marcella, De Maria, Ruggero, Maugeri-Saccà, Marcello
Published in Oncotarget (2015)

Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study

by Vici, Patrizia, Pizzuti, Laura, Natoli, Clara, Moscetti, Luca, Mentuccia, Lucia, Vaccaro, Angela, Sergi, Domenico, Di Lauro, Luigi, Trenta, Patrizia, Seminara, Patrizia, Santini, Daniele, Iezzi, Laura, Tinari, Nicola, Bertolini, Ilaria, Sini, Valentina, Mottolese, Marcella, Giannarelli, Diana, Giotta, Francesco, Maugeri-Saccà, Marcello, Barba, Maddalena, Marchetti, Paolo, Michelotti, Andrea, Sperduti, Isabella, Gamucci, Teresa
Published 2014

Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study

by Pizzuti, Laura, Marchetti, Paolo, Natoli, Clara, Gamucci, Teresa, Santini, Daniele, Scinto, Angelo Fedele, Iezzi, Laura, Mentuccia, Lucia, D’Onofrio, Loretta, Botticelli, Andrea, Moscetti, Luca, Sperati, Francesca, Botti, Claudio, Ferranti, Francesca, Buglioni, Simonetta, Sanguineti, Giuseppe, Di Filippo, Simona, di Lauro, Luigi, Sergi, Domenico, Catenaro, Teresa, Tomao, Silverio, Giordano, Antonio, Maugeri-Saccà, Marcello, Barba, Maddalena, Vici, Patrizia
Published in Sci Rep (2017)

A Real‐World Multicentre Retrospective Study of Paclitaxel‐Bevacizumab and Maintenance Therapy as First‐Line for HER2‐Negative Metastatic Breast Cancer

by Gamucci, Teresa, Mentuccia, Lucia, Natoli, Clara, Sperduti, Isabella, Cassano, Alessandra, Michelotti, Andrea, Di Lauro, Luigi, Sergi, Domenico, Fabi, Alessandra, Sarobba, Maria G., Marchetti, Paolo, Barba, Maddalena, Magnolfi, Emanuela, Maugeri‐Saccà, Marcello, Rossi, Ernesto, Sini, Valentina, Grassadonia, Antonino, Pellegrini, Domenica, Astone, Antonino, Nisticò, Cecilia, Angelini, Franco, Vaccaro, Angela, Pellegrino, Arianna, De Angelis, Claudia, Palleschi, Michela, Moscetti, Luca, Bertolini, Ilaria, Buglioni, Simonetta, Giordano, Antonio, Pizzuti, Laura, Vici, Patrizia
Published in J Cell Physiol (2016)